| Amgen (AMGN) |
United States |
$131.810B |
15.07 |
| CSL (CSLLY) |
Australia |
$100.765B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$85.473B |
11.00 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$63.215B |
57.37 |
| Biogen (BIIB) |
United States |
$57.963B |
9.90 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$43.958B |
18.62 |
| Illumina (ILMN) |
United States |
$43.941B |
45.43 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$22.707B |
10.56 |
| Seattle Genetics (SGEN) |
United States |
$20.339B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$19.638B |
0.00 |
| Incyte (INCY) |
United States |
$17.006B |
36.49 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.988B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$14.741B |
65.11 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$14.490B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$14.198B |
36.58 |
| Exact Sciences (EXAS) |
United States |
$12.747B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$12.078B |
56.43 |
| BeiGene (BGNE) |
Cayman Islands |
$10.449B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$9.349B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$8.375B |
25.79 |
| Bio-Techne Corp (TECH) |
United States |
$7.997B |
54.73 |
| Guardant Health (GH) |
United States |
$7.916B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$7.099B |
0.00 |
| BioNTech SE (BNTX) |
Germany |
$6.958B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$6.831B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$6.732B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$6.730B |
17.11 |
| Moderna (MRNA) |
United States |
$6.394B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.311B |
17.75 |
| Amarin (AMRN) |
Ireland |
$6.294B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$6.105B |
0.00 |
| Repligen (RGEN) |
United States |
$5.517B |
99.97 |
| Acceleron Pharma (XLRN) |
United States |
$4.972B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$4.942B |
0.00 |
| China Biologic Products (CBPO) |
China |
$4.597B |
25.89 |
| Adaptive Biotechnologies (ADPT) |
United States |
$3.913B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.898B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$3.635B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$3.619B |
0.00 |
| NeoGenomics (NEO) |
United States |
$3.569B |
189.89 |
| Immunomedics (IMMU) |
United States |
$3.550B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.532B |
0.00 |
| Zai Lab (ZLAB) |
China |
$3.517B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.395B |
57.53 |
| Emergent Biosolutions (EBS) |
United States |
$3.261B |
32.40 |
| MyoKardia (MYOK) |
United States |
$3.254B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$3.157B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$3.104B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$3.092B |
0.00 |
| Genmab (GMAB) |
Denmark |
$3.074B |
6.33 |
| Alkermes (ALKS) |
Ireland |
$2.804B |
222.13 |
| Amicus Therapeutics (FOLD) |
United States |
$2.798B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.756B |
0.00 |
| Insmed (INSM) |
United States |
$2.737B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$2.706B |
6.29 |
| Denali Therapeutics (DNLI) |
United States |
$2.441B |
0.00 |
| Epizyme (EPZM) |
United States |
$2.209B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$2.201B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$2.183B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$2.120B |
0.00 |
| Alector (ALEC) |
United States |
$2.068B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.980B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.889B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.708B |
49.86 |
| Arvinas (ARVN) |
United States |
$1.698B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$1.686B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.595B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.525B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.465B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.456B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.448B |
25.55 |
| Editas Medicine (EDIT) |
United States |
$1.376B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.292B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$1.266B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.212B |
0.00 |
| Athenex (ATNX) |
United States |
$1.206B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.184B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.143B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$1.070B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.020B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$1.014B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.948B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.908B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.878B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.877B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.861B |
0.00 |
| Vericel (VCEL) |
United States |
$0.852B |
317.83 |
| Codexis (CDXS) |
United States |
$0.821B |
0.00 |
| Heska (HSKA) |
United States |
$0.807B |
206.14 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.794B |
13.54 |
| Cellectis S.A (CLLS) |
France |
$0.742B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.712B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.712B |
0.00 |
| Intrexon (PGEN) |
United States |
$0.695B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.694B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.678B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.677B |
5.70 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.640B |
0.00 |
| NantKwest (NK) |
United States |
$0.620B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.592B |
19.20 |
| UROGEN PHARMA (URGN) |
United States |
$0.586B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.586B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.576B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.576B |
13.31 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.552B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.538B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.521B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.517B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.506B |
0.00 |
| Agenus (AGEN) |
United States |
$0.503B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.493B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.477B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.472B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.463B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.460B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.456B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.449B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.437B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.436B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.434B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.421B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.421B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.420B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.419B |
10.49 |
| AnaptysBio (ANAB) |
United States |
$0.415B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.399B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.383B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.369B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.345B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.339B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.334B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.329B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.324B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.314B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.308B |
2.13 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.302B |
0.00 |
| MannKind (MNKD) |
United States |
$0.301B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.290B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.290B |
12.06 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.277B |
0.00 |
| IVERIC Bio (ISEE) |
United States |
$0.273B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.273B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.272B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.271B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.264B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.264B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.260B |
0.00 |
| Geron (GERN) |
United States |
$0.258B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.256B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.253B |
0.00 |
| Novavax (NVAX) |
United States |
$0.247B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.246B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.244B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.239B |
0.00 |
| XOMA (XOMA) |
United States |
$0.238B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.236B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.227B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.222B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.221B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.215B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.210B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.210B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.208B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.208B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.205B |
0.00 |
| Exicure (XCUR) |
United States |
$0.205B |
0.00 |
| Cerecor (CERC) |
United States |
$0.201B |
0.00 |
| Athersys (ATHX) |
United States |
$0.194B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.193B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.192B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.180B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.178B |
4.77 |
| Spero Therapeutics (SPRO) |
United States |
$0.172B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.168B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.165B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.162B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.157B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.157B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.154B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.152B |
0.00 |
| Verastem (VSTM) |
United States |
$0.149B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.143B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.142B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.137B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.136B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.135B |
0.00 |
| Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.134B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.124B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.119B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.115B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.115B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.112B |
0.00 |
| OvaScience (MLND) |
United States |
$0.107B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.106B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.104B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.103B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.094B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.093B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.092B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.091B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.090B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.090B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.087B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.086B |
0.00 |
| Adocia (ADOCY) |
France |
$0.086B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.085B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.084B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.083B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.079B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.079B |
5.08 |
| Synlogic (SYBX) |
United States |
$0.078B |
0.00 |
| Trevena (TRVN) |
United States |
$0.072B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.072B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.067B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.061B |
0.00 |
| China Health Industries Holdings (CHHE) |
China |
$0.058B |
17.78 |
| NewLink Genetics (NLNK) |
United States |
$0.058B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.058B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.056B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.052B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.049B |
0.00 |
| Curis (CRIS) |
United States |
$0.048B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.046B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.043B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.041B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.039B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.037B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.036B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.036B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.032B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.031B |
0.00 |
| Celsion (CLSN) |
United States |
$0.031B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.030B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.029B |
0.00 |
| Stellar Biotechnologies (EDSA) |
Canada |
$0.029B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.028B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.028B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.027B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.027B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.025B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.025B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.024B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.024B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.022B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.022B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.017B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.016B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.016B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.015B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.013B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.013B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.013B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.013B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.012B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.012B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.010B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.006B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.004B |
0.00 |
